• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

Non-lipid risk factors in the development of metabolic syndrome: A case control study

    Dr. Amit VasantDeshpande, Dr. Vijaya Lokary, Dr. Baer Philip Ravikumar .

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 4555-4560

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Recently, there has been an interest in identifying non-lipid risk factors in the causation of metabolic syndrome.
Objectives: The present study was aimed to assess the significance of high sensitivity C-reactive protein (hs-CRP)and thyroid profile in patients with metabolic syndrome.
Materials and methods: Patients diagnosed with metabolic syndrome in the outpatient clinic of Department of Medicine were included. Those having ≥3 components of the metabolic syndrome criteria constituted the cases and those with less than three components constituted the controls. Various biochemical parameters were compared between cases and control.
Results: Mean hs-CRP was significantly higher among cases (2.9 ± 0.8mg/L) as compared to controls (1.1 ± 0.7 mg/L), p value 0.5). The clinical thyroid status of the cases was compared against that of control. Among those with metabolic syndrome, overt hypothyroidism was observed in 18.4% and 3% had subclinical hypothyroidism, while among controls, only 4.6% had overt hypothyroidism.
Conclusion: Patients with metabolic syndrome had significantly higher levels of hs-CRP. Though the mean TSH levels were similar, thyroid dysfunction was significantly more common in cases with metabolic syndrome
Keywords:
    metabolic syndrome risk factors hs-CRP Thyroid stimulating hormone
  • PDF (403 K)
  • XML
(2023). Non-lipid risk factors in the development of metabolic syndrome: A case control study. European Journal of Molecular & Clinical Medicine, 10(1), 4555-4560.
Dr. Amit VasantDeshpande, Dr. Vijaya Lokary, Dr. Baer Philip Ravikumar .. "Non-lipid risk factors in the development of metabolic syndrome: A case control study". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 4555-4560.
(2023). 'Non-lipid risk factors in the development of metabolic syndrome: A case control study', European Journal of Molecular & Clinical Medicine, 10(1), pp. 4555-4560.
Non-lipid risk factors in the development of metabolic syndrome: A case control study. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 4555-4560.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 15
  • PDF Download: 22
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus